Health care companies in the United States by short interest
Shares sold short and not yet covered, as reported to FINRA for the latest settlement date, as a percent of shares outstanding (market value divided by share price), not of the smaller float.
Hims & Hers Health leads the 140 health care companies in the United States ranked by short interest, at 22.0%, ahead of Scholar Rock Holding (19.2%) and TG Therapeutics (19.0%). Figures as of the 30 Oct 2026 settlement date, from FINRA's short interest report, with shares outstanding from Yahoo Finance quotes.
Key facts
- Companies ranked
- 140
- First
- Hims & Hers Health22.0%
- Median
- 5.35%
- Combined market value
- AED 26.81T
- Countries
- 1
Market values as of .
United States▾
Health Care▾
All categories▾
| # | Company | Short interest % ↓ | Market cap | Price | Today | 1 year | Price, 30 days | Country |
|---|---|---|---|---|---|---|---|---|
| 1 | Hims & Hers HealthHIMS · Health Care | 22.0% | AED 12.6B | AED 53.62 | 8.86% down | 54% down | ||
| 2 | Scholar Rock HoldingSRRK · Health Care | 19.2% | AED 21.6B | AED 176.76 | 4.45% down | 25% up | ||
| 3 | TG TherapeuticsTGTX · Health Care | 19.0% | AED 35.2B | AED 232.62 | 2.37% down | 103% up | ||
| 4 | GRAILGRAL · Health Care | 17.8% | AED 16.4B | AED 364.51 | 5.33% down | 12% up | ||
| 5 | Rhythm PharmaceuticalsRYTM · Health Care | 16.8% | AED 28.6B | AED 412.65 | 3.80% down | 15% up | ||
| 6 | Dianthus TherapeuticsDNTH · Health Care | 16.5% | AED 17.5B | AED 310.52 | 0.33% down | 105% up | ||
| 7 | Protagonist TherapeuticsPTGX · Health Care | 15.7% | AED 29.1B | AED 445.85 | 2.11% down | 45% up | ||
| 8 | Praxis Precision MedicinesPRAX · Health Care | 15.1% | AED 30.8B | AED 1,103.36 | 3.37% down | 83% up | ||
| 9 | Twist BioscienceTWST · Health Care | 14.4% | AED 25.9B | AED 379.45 | 7.44% down | 291% up | ||
| 10 | CytokineticsCYTK · Health Care | 12.9% | AED 26B | AED 186.49 | 1.32% down | 21% down | ||
| 11 | Ionis PharmaceuticalsIONS · Health Care | 12.7% | AED 16.3B | AED 97.62 | 2.35% down | 64% down | ||
| 12 | Kodiak SciencesKOD · Health Care | 12.4% | AED 23.3B | AED 356.87 | 0.75% down | 371% up | ||
| 13 | Ligand PharmaceuticalsLGND · Health Care | 12.3% | AED 21.1B | AED 1,053.49 | 0.03% down | 44% up | ||
| 14 | Spyre TherapeuticsSYRE · Health Care | 12.2% | AED 32.6B | AED 343.28 | 4.26% down | 302% up | ||
| 15 | Halozyme TherapeuticsHALO · Health Care | 12.0% | AED 38.2B | AED 335.49 | 1.82% down | 32% up | ||
| 16 | ImmunityBioIBRX · Health Care | 11.9% | AED 23.5B | AED 22.11 | 8.37% down | 216% up | ||
| 17 | Edgewise TherapeuticsEWTX · Health Care | 11.6% | AED 16B | AED 146.56 | 3.07% down | 82% up | ||
| 18 | RadNetRDNT · Health Care | 11.3% | AED 20.2B | AED 256.02 | 0.29% up | 16% down | ||
| 19 | RepligenRGEN · Health Care | 11.0% | AED 38.5B | AED 601.61 | 3.81% down | 5% up | ||
| 20 | BridgeBio PharmaBBIO · Health Care | 10.7% | AED 54.4B | AED 279.23 | 2.75% down | 15% up | ||
| 21 | ErascaERAS · Health Care | 10.6% | AED 17.5B | AED 49.98 | 4.29% down | 387% up | ||
| 22 | ExelixisEXEL · Health Care | 10.5% | AED 57.9B | AED 237.36 | 1.82% down | 55% up | ||
| 23 | CG OncologyCGON · Health Care | 10.3% | AED 26.1B | AED 291.86 | 2.97% down | 93% up | ||
| 24 | Krystal BiotechKRYS · Health Care | 10.3% | AED 33.6B | AED 1,134.43 | 2.19% down | 49% up | ||
| 25 | TeleflexTFX · Health Care | 10.3% | AED 23.5B | AED 593.42 | 1.11% down | 48% up | ||
| 26 | Cogent BiosciencesCOGT · Health Care | 10.0% | AED 17.1B | AED 98.11 | 3.70% down | 25% down | ||
| 27 | Mirum PharmaceuticalsMIRM · Health Care | 9.99% | AED 23B | AED 353.05 | 0.65% up | 35% up | ||
| 28 | Travere TherapeuticsTVTX · Health Care | 9.96% | AED 16.6B | AED 172.61 | 2.69% down | 39% up | ||
| 29 | Kymera TherapeuticsKYMR · Health Care | 9.84% | AED 36.2B | AED 423.49 | 3.42% down | 81% up | ||
| 30 | VaxcytePCVX · Health Care | 9.70% | AED 32.2B | AED 203.43 | 5.09% down | 22% up | ||
| 31 | Oruka TherapeuticsORKA · Health Care | 9.53% | AED 23.9B | AED 351.87 | 1.80% down | 233% up | ||
| 32 | 10x GenomicsTXG · Health Care | 9.48% | AED 25B | AED 190.24 | 9.72% down | 213% up | ||
| 33 | PTC TherapeuticsPTCT · Health Care | 9.31% | AED 17.3B | AED 207.21 | 3.27% down | 26% down | ||
| 34 | Madrigal PharmaceuticalsMDGL · Health Care | 9.20% | AED 32.3B | AED 1,392.28 | 4.45% down | 28% down | ||
| 35 | ImmunovantIMVT · Health Care | 8.96% | AED 24.1B | AED 116.68 | 2.31% down | 44% up | ||
| 36 | Henry ScheinHSIC · Health Care | 8.47% | AED 33.9B | AED 306.74 | 1.51% down | 16% up | ||
| 37 | Corcept TherapeuticsCORT · Health Care | 8.34% | AED 25.6B | AED 233.65 | 2.09% down | 16% down | ||
| 38 | ModernaMRNA · Health Care | 8.20% | AED 289.8B | AED 716.16 | 2.17% down | 740% up | ||
| 39 | Arrowhead PharmaceuticalsARWR · Health Care | 8.19% | AED 21.5B | AED 151.94 | 5.22% down | 8% up | ||
| 40 | DaVitaDVA · Health Care | 8.17% | AED 37.2B | AED 591.40 | 3.00% up | 30% up | ||
| 41 | VeradermicsMANE · Health Care | 8.03% | AED 18.5B | AED 438.95 | 3.92% down | 230% up | ||
| 42 | HaemoneticsHAE · Health Care | 7.90% | AED 20.1B | AED 441.30 | 0.17% down | 53% up | ||
| 43 | InsuletPODD · Health Care | 7.68% | AED 33.9B | AED 489.08 | 2.96% down | 59% down | ||
| 44 | GlaukosGKOS · Health Care | 7.57% | AED 51.6B | AED 871.54 | 0.33% down | 139% up | ||
| 45 | ResMedRMD · Health Care | 7.44% | AED 121.7B | AED 865.37 | 0.53% down | 6% down | ||
| 46 | BrukerBRKR · Health Care | 7.37% | AED 31.7B | AED 207.35 | 9.08% down | 31% up | ||
| 47 | BioMarin PharmaceuticalBMRN · Health Care | 7.29% | AED 43B | AED 221.86 | 1.64% down | 12% up | ||
| 48 | Globus MedicalGMED · Health Care | 7.14% | AED 32.5B | AED 245.66 | 2.49% down | 20% down | ||
| 49 | Adaptive BiotechnologiesADPT · Health Care | 7.09% | AED 16.6B | AED 102.58 | 0.43% down | 51% up | ||
| 50 | Definium TherapeuticsDFTX · Health Care | 7.02% | AED 14.2B | AED 104.08 | 3.87% down | 176% up | ||
| 51 | Guardant HealthGH · Health Care | 6.97% | AED 72.5B | AED 535.58 | 0.16% up | 38% up | ||
| 52 | Merit Medical SystemsMMSI · Health Care | 6.67% | AED 18.6B | AED 309.75 | 0.08% down | 3% down | ||
| 53 | HealthEquityHQY · Health Care | 6.62% | AED 28.8B | AED 347.98 | 2.70% down | 4% down | ||
| 54 | Elanco Animal HealthELAN · Health Care | 6.59% | AED 47.3B | AED 94.53 | 2.09% down | 18% up | ||
| 55 | HeartflowHTFL · Health Care | 6.47% | AED 15.1B | AED 171.47 | 4.62% up | 45% up | ||
| 56 | InsmedINSM · Health Care | 6.42% | AED 113.9B | AED 519.05 | 2.17% down | 27% down | ||
| 57 | Charles River Laboratories InternationalCRL · Health Care | 6.23% | AED 55.3B | AED 1,154.37 | 4.15% down | 96% up | ||
| 58 | BillionToOneBLLN · Health Care | 6.22% | AED 15.8B | AED 330.24 | 0.31% down | 18% down | ||
| 59 | Axsome TherapeuticsAXSM · Health Care | 6.20% | AED 25B | AED 475.09 | 4.66% down | 9% down | ||
| 60 | ChemedCHE · Health Care | 6.14% | AED 26.1B | AED 2,014.75 | 0.50% down | 25% up | ||
| 61 | Legend BiotechLEGN · Health Care | 6.13% | AED 10.9B | AED 56.01 | 5.28% down | 43% down | ||
| 62 | PenumbraPEN · Health Care | 6.10% | AED 46.2B | AED 1,172.00 | 0.28% down | 11% up | ||
| 63 | Revolution MedicinesRVMD · Health Care | 6.05% | AED 128.1B | AED 592.02 | 1.11% up | 125% up | ||
| 64 | RevvityRVTY · Health Care | 5.85% | AED 59.5B | AED 533.33 | 4.20% down | 54% up | ||
| 65 | BrightSpring Health ServicesBTSG · Health Care | 5.83% | AED 45.9B | AED 230.79 | 1.84% down | 85% up | ||
| 66 | Align TechnologyALGN · Health Care | 5.83% | AED 40.2B | AED 569.88 | 2.82% down | 12% up | ||
| 67 | Neurocrine BiosciencesNBIX · Health Care | 5.83% | AED 56B | AED 552.98 | 3.84% down | 10% up | ||
| 68 | Molina HealthcareMOH · Health Care | 5.59% | AED 38B | AED 728.61 | 2.43% down | 44% up | ||
| 69 | Lantheus HoldingsLNTH · Health Care | 5.57% | AED 24.5B | AED 374.97 | 0.00% | 83% up | ||
| 70 | Oscar HealthOSCR · Health Care | 5.39% | AED 28.2B | AED 90.82 | 5.50% down | 94% up | ||
| 71 | Cooper CompaniesCOO · Health Care | 5.32% | AED 41.1B | AED 216.24 | 2.40% down | 20% down | ||
| 72 | IlluminaILMN · Health Care | 5.31% | AED 107.1B | AED 708.15 | 3.90% down | 62% up | ||
| 73 | Summit TherapeuticsSMMT · Health Care | 5.28% | AED 29.2B | AED 36.54 | 5.87% down | 35% down | ||
| 74 | IncyteINCY · Health Care | 5.22% | AED 85.8B | AED 420.97 | 1.07% down | 14% up | ||
| 75 | Medpace HoldingsMEDP · Health Care | 4.95% | AED 62.7B | AED 2,242.27 | 3.70% down | 7% up | ||
| 76 | Bio-TechneTECH · Health Care | 4.90% | AED 41.9B | AED 266.89 | 0.04% down | 18% up | ||
| 77 | Baxter InternationalBAX · Health Care | 4.58% | AED 48.2B | AED 93.25 | 0.00% | 39% up | ||
| 78 | Universal Health ServicesUHS · Health Care | 4.42% | AED 38B | AED 658.97 | 2.54% up | 25% down | ||
| 79 | United TherapeuticsUTHR · Health Care | 4.31% | AED 86.8B | AED 2,037.30 | 0.78% down | 18% up | ||
| 80 | Bio-Rad LaboratoriesBIO · Health Care | 4.30% | AED 35.4B | AED 1,318.10 | 2.34% down | 16% up | ||
| 81 | DexComDXCM · Health Care | 4.27% | AED 108.6B | AED 291.31 | 1.08% down | 33% up | ||
| 82 | NateraNTRA · Health Care | 4.19% | AED 145.6B | AED 1,004.09 | 5.70% down | 26% up | ||
| 83 | Zimmer Biomet HoldingsZBH · Health Care | 4.15% | AED 70.3B | AED 371.30 | 0.36% down | 10% up | ||
| 84 | ZoetisZTS · Health Care | 4.12% | AED 118.1B | AED 290.54 | 2.08% down | 34% down | ||
| 85 | Option Care HealthOPCH · Health Care | 4.10% | AED 17.4B | AED 116.02 | 0.06% down | 7% up | ||
| 86 | Alnylam PharmaceuticalsALNY · Health Care | 4.08% | AED 70.7B | AED 528.19 | 2.71% down | 66% down | ||
| 87 | GE HealthCare TechnologiesGEHC · Health Care | 4.04% | AED 133.9B | AED 296.16 | 1.53% down | 7% up | ||
| 88 | Caris Life SciencesCAI · Health Care | 4.01% | AED 18.5B | AED 64.56 | 5.18% down | 23% down | ||
| 89 | AvantorAVTR · Health Care | 3.97% | AED 36.9B | AED 54.50 | 1.85% down | 31% up | ||
| 90 | BiogenBIIB · Health Care | 3.69% | AED 135.5B | AED 916.64 | 1.00% up | 41% up | ||
| 91 | Encompass HealthEHC · Health Care | 3.68% | AED 48.2B | AED 490.84 | 1.04% up | 16% up | ||
| 92 | LifeStance Health GroupLFST · Health Care | 3.59% | AED 19.3B | AED 50.76 | 3.60% up | 107% up | ||
| 93 | MiniMed GroupMMED · Health Care | 3.49% | AED 16.5B | AED 58.80 | 1.54% down | 12% down | ||
| 94 | Belite BioBLTE · Health Care | 3.40% | AED 19B | AED 467.82 | 15.65% down | 25% up | ||
| 95 | Quest DiagnosticsDGX · Health Care | 3.39% | AED 104.4B | AED 948.56 | 0.31% down | 35% up | ||
| 96 | Cardinal HealthCAH · Health Care | 3.28% | AED 231.6B | AED 1,001.92 | 0.17% up | 30% up | ||
| 97 | Amneal PharmaceuticalsAMRX · Health Care | 3.27% | AED 27B | AED 77.57 | 1.26% down | 79% up | ||
| 98 | Labcorp HoldingsLH · Health Care | 3.13% | AED 109.5B | AED 1,348.32 | 0.47% down | 39% up | ||
| 99 | Mettler-Toledo InternationalMTD · Health Care | 3.10% | AED 121.8B | AED 6,121.78 | 2.27% down | 17% up | ||
| 100 | ViatrisVTRS · Health Care | 3.07% | AED 82.7B | AED 72.09 | 1.26% down | 90% up |
Sources: share prices and market values from Yahoo Finance; sector, country and category from each company's SEC registration; short interest from FINRA, the owner and source of the data, as of the 30 Oct 2026 settlement date.
Market value is share price × shares outstanding, from Yahoo Finance; prices may be delayed 15 minutes or more and the ranking refreshes about every 20 minutes. The list covers companies with shares listed in the US, which includes foreign companies listed through ADRs but not ones listed only abroad. Sector, category and country come from each company's SEC registration. Source: FINRA. Short interest is the shares sold short and not yet covered as brokers reported them to FINRA for the 30 Oct 2026 settlement date; FINRA publishes it about seven business days later, so it is not today's figure. It is divided by shares outstanding worked out as the market value over the share price, both from the same quote — not by the float, so the percent reads lower than a percent of float would. For a company with more than one class of shares the market value covers every class, which lowers it further. Sums are converted from US dollars at today's exchange rate (1 USD = 3.6726 AED).
Questions and answers
Which health care companies in the United States rank first by short interest?
Hims & Hers Health (22.0%), Scholar Rock Holding (19.2%) and TG Therapeutics (19.0%) are the top three of the 140 health care companies in the United States ranked by short interest as of the 30 Oct 2026 settlement date.
How many health care companies in the United States are in this ranking?
140 are ranked by short interest.
What are these health care companies in the United States worth together?
The 140 health care companies in the United States ranked by short interest have a combined market value of AED 26.81T as of the 30 Oct 2026 settlement date.
What does ranking by short interest measure?
Shares sold short and not yet covered, as reported to FINRA for the latest settlement date, as a percent of shares outstanding (market value divided by share price), not of the smaller float.
Learn how this ranking works
All markets guides →- How an ETF's size is measured: AUM, NAV and creation units
An ETF's size is usually measured by its assets under management (AUM), the fund's net assets: everything it holds minus what it owes. That equals net asset value per share times shares outstanding. AUM grows when the holdings rise in value and when large institutions create new shares, and shrinks when they redeem them.
- How companies are sorted into sectors and industries
Companies are sorted into sectors and industries by classification systems. The index providers MSCI and S&P Dow Jones Indices use GICS: 11 sectors split into 25 industry groups, 74 industries and 163 sub-industries. SEC filings carry a four-digit SIC code. The two can place one company differently, because each looks at the business from its own angle.
- Market cap vs enterprise value: what is the difference?
Market capitalization is the value of a company's shares. Enterprise value is market cap plus debt, minus cash: roughly what it would cost to buy the whole business and settle its borrowings. Two companies with the same $50 billion market cap can have very different enterprise values if one owes $20 billion and the other holds $20 billion in cash.
Cite this page
Funkfolio, “Health care companies in the United States by short interest”, data as of 21 November 2026. https://funkfolio.com/companies/sector/health-care?country=united-states&by=short-interest
Underlying data: FINRA short interest (the 30 Oct 2026 settlement date); Yahoo Finance.